Endothelin receptor antagonist

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

A endothelin receptor antagonist (ERA) is a drug which blocks endothelin receptors.

Two main kinds of ERAs exist:

selective ERA (e.g. sitaxsentan), which affect endothelin A.
dual ERAs,(e.g. bosentan) which affect both endothelin A and B .^[1]

References

↑ http://cvpharmacology.com/vasodilator/ETblockers.htm

Template:PAH rx

Template:WikiDoc Sources

[1] ttp://cvpharmacology.com/vasodilator/ETblockers.htm

[1]

v t e Antihypertensives (C02) and diuretics (C03)
Sympatholytic agents	Template:Navbox subgroup
Vasodilators	Diazoxide • hydrazinophthalazine (Hydralazine, Dihydralazine, Endralazine, Cadralazine) • Minoxidil • Nitroprusside • Phentolamine
Other antihypertensives	serotonin antagonist (Ketanserin) • endothelin receptor antagonist (Bosentan, Ambrisentan, Sitaxsentan) • MAOI (Pargyline) • THI (Metirosine)
Diuretics	Template:Navbox subgroup

Endothelin receptor antagonist

See also

References

Navigation menu